VEGF-mediated proliferation of human adipose tissue-derived stem cells.

Guangfeng Chen,Xiujuan Shi,Chen Sun,Min Li,Qing Zhou,Chen Zhang,Jun Huang,Yu Qiu,Xiangyi Wen,Yan Zhang,Yushan Zhang,Shuzhang Yang,Lixia Lu,Jieping Zhang,Qionglan Yuan,Jianwei Lu,Guotong Xu,Yunyun Xue,Zibing Jin,Cizhong Jiang,Ming Ying,Xiaoqing Liu
DOI: https://doi.org/10.1371/journal.pone.0073673
IF: 3.7
2013-01-01
PLoS ONE
Abstract:Human adipose tissue-derived stem cells (ADSCs) are an attractive multipotent stem cell source with therapeutic applicability across diverse fields for the repair and regeneration of acute and chronically damaged tissues. In recent years, there has been increasing interest in ADSC for tissue engineering applications. However, the mechanisms underlying the regulation of ADSC proliferation are not fully understood. Here we show that 47 transcripts are up-regulated while 23 are down-regulated in ADSC compared to terminally differentiated cells based on global mRNA profiling and microRNA profiling. Among the up-regulated genes, the expression of vascular endothelial growth factor (VEGF) is fine-tuned by miR-199a-5p. Further investigation indicates that VEGF accelerates ADSC proliferation whereas the multipotency of ADSC remains stable in terms of adipogenic, chondrogenic and osteogenic potentials after VEGF treatment, suggesting that VEGF may serve as an excellent supplement for accelerating ADSC proliferation during in vitro expansion.
What problem does this paper attempt to address?